University Spin-Out Receives Drug Research Grant

Posted in
(Photo courtesy of the University of Wyoming)
(Photo courtesy of the University of Wyoming)

A University of Wyoming spin-out business has received a 150-thousand dollar grant to improve the effectiveness of drugs that can potentially help diabetes and cancer patients. Christoph Geisler is the chief research scientist for the company GlycoBac. He says the grant is through the National Institutes of Health Small Business Innovation Research Program. It will allow the company to improve the effectiveness of already-produced drugs.

The company was founded by Geisler and UW Molecular Biology Professor Don Jarvis. They hold a licensing agreement that allows them to use genetically engineered insect cells for manufacturing vaccines, diagnostics or therapeutics.

Visit First Northern Bank
view counter
We will soon be requiring people to use their real names for comments. Please take a couple moments to edit your Disqus accounts to reflect this change. You can edit your user name here.

Send us a News Tip!

Have a news tip?
Use our anonymous form to let us know.